GlassScriptPhysician profile
Amber N Toombs
NPI 1497910624
$11,654.94
in general payments reported to CMS, 2019-2025
17 companies · $231 in 2025
The $231 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $9,356 · 2022: $1,572 · 2023: $424 · 2024: $71.76 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $726.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $8,383.59 | 2021-2023 | |
| Novo Nordisk INC | $2,242.00 | 2021 | |
| Lilly USA, LLC | $345.37 | 2021-2025 | Mounjaro, Trulicity, Humulin |
| Astrazeneca Pharmaceuticals LP | $176.49 | 2021-2024 | Farxiga |
| Sequel Med Tech, LLC | $107.67 | 2025 | Twiist |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.54 | 2021-2025 | Jardiance |
| Medtronic, INC. | $61.08 | 2025 | Minimed 780g, Intellis Adaptivestim |
| Bayer Healthcare Pharmaceuticals INC. | $51.78 | 2023 | |
| Dexcom, INC. | $38.51 | 2022 | |
| Phathom Pharmaceuticals, INC. | $24.83 | 2024-2025 | Voquezna |
| Aurinia Pharma U.S., INC. | $22.11 | 2023 | Lupkynis |
| Otsuka America Pharmaceutical, INC. | $21.65 | 2023 | Rexulti |
| Nevro Corp. | $16.84 | 2023 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.80 | 2023 | Xifaxan |
| Beta Bionics, INC. | $15.89 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $13.85 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Insulet Corporation | $12.94 | 2023 | Omnipod |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Toombs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.